Healthcare-focused venture capital firm W Health Ventures has announced the first close of its second fund at Rs 550 crore, marking a significant step in its continued bet on technology-led healthcare startups.
The firm has set a target corpus of around Rs 630 crore for Fund II and plans to back 8–10 early stage healthcare ventures over the investment cycle.
Investment Strategy and Focus Areas
W Health Ventures will invest Rs 30–50 crore per startup, primarily at the early stage. The fund will continue to follow its distinctive company creation and incubation model, working closely with founders from the idea stage to build scalable healthcare businesses.
Fund II will focus on high growth segments such as:
- AI-enabled healthcare services
- Chronic care management
- Preventive care
- Geriatrics
- Oncology
- Innovative healthcare delivery models
The strategy reflects rising demand for tech-driven healthcare solutions amid increasing chronic disease burden and ageing populations in India and globally.
Cross-Border Healthcare Thesis
Founded in 2019, W Health Ventures invests across India and the United States, supporting startups operating in care delivery, digital health, and technology enabled healthcare services.
The firm has already begun deploying capital from the first close and expects to complete the final close in the coming months.
Portfolio and Track Record
W Health Ventures’ existing portfolio includes startups such as Wysa and BeatO, among other digital health and care delivery ventures across India and the US.
With Fund II, the firm aims to deepen its footprint in AI-driven and preventive healthcare models, aligning with the broader shift toward outcome based, technology-first health services.
Follow Startupbydoc for daily startup insights, funding news, IPO analysis, and business breakdowns.